Erlanger Medical Group welcomes Dr. Sandeep Rajan as the medical director of Erlanger Oncology and Hematology, which is a collaborative, comprehensive cancer care partnership between Erlanger Health System and Vanderbilt-Ingram Cancer Center (VICC). He is also an associate professor of medicine at Vanderbilt University.
Born in India, Dr. Rajan received his Bachelor of Medicine, Bachelor of Science (MBBS) from Maulana Azad Medical College in New Delhi.
He completed a residency in internal medicine and his fellowship training at LAC + USC Medical Center in Los Angeles.
“Dr. Rajan is a welcome addition to Erlanger Oncology and Hematology,” said Meridith O’Keefe, senior vice president of Erlanger Medical Group. “He brings a great deal of knowledge and experience to our exceptional team, and we look forward to seeing his impact on our community.”
Dr. Rajan has been involved in many non-malignant hematology clinical and translational research programs with the development of clinical trials in conjunction with local researchers. His clinical and research interests include hemophilia and bleeding disorders, thrombosis and clotting disorders, non-malignant and malignant hematological disorders, myelodysplastic syndrome, Hodgkin’s disease, chronic lymphocytic leukemia, lymphomas, myelomas, and plasma cell dyscrasia.
“Vanderbilt-Ingram Cancer Center is proud to have Dr. Rajan take the lead in providing our hematology and oncology services at Erlanger Health System,” said Senior Medical Director for VICC Cancer Care Network and Strategy Dr. Nancy Davis. “He brings a wealth of experience in both clinical cancer care and research to Chattanooga, and, as a sub-specialist in hemophilia and sickle cell diseases, he offers Erlanger the expertise to continue care of this population as they age out of traditional pediatric care.”